Products for Research Use Only
RegisterLogin

(S) -GLPG0974

CAT: 0804-HY-12940A-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-12940A-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
(S) -GLPG0974 is the isomer of GLPG0974 , and can be used as an experimental control. GLPG0974 is a free fatty acid receptor-2 (FFA2/GPR43) antagonist with an IC50 of 9 nM.
CAS Number
2326220-69-1
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Free Fatty Acid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/s-glpg0974.html
Purity
98.79
Solubility
DMSO : 105 mg/mL (ultrasonic)
Smiles
O=C(O)CCCN(C([C@@]1(C)N(C(C2=CSC3=CC=CC=C32)=O)CC1)=O)CC4=CC=CC(Cl)=C4
Molecular Formula
C25H25ClN2O4S
Molecular Weight
485.00
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Pizzonero M, et al. Discovery and optimization of an azetidine chemical series as a free fatty acid receptor 2 (FFA2) antagonist: from hit to clinic. J Med Chem. 2014 Dec 11;57 (23) :10044-57.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-12940-01GLPG0974
HY-125845B(S, S, S) -AHPC
HY-120217A(S, S, S) -VH032
HY-172298(R, S, S, S) -Orlistat
HY-112078B(S, S, S) -AHPC-Me
HY-125845A-01(S, S, S) -AHPC (hydrochloride)
HY-123109A-01(S, S, S) -AHPC-Boc
HY-78931B-01(S, S, S, S, R) -Boc-Dap-NE
HY-130671B(S, S) -DPPG
HY-122715(S, S) -D211

Alternative Products

CatalogName
T15388-01GLPG0974
A21466-5GLPG0974 5mg
GTR19269008-01(S) -GLPG0974
A21466-50GLPG0974 50mg
A21466-25GLPG0974 25mg
A21466-10GLPG0974 10mg
A21466-100GLPG0974 100mg
A21466-1GLPG0974 1mg
A21466-10mM-DGLPG0974 10mM * 1mL in DMSO

Popular Products